Matches in DBpedia 2016-04 for { <https://www.ncbi.nlm.nih.gov/pubmed/10690517> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- 10690517 first1 "SJ".
- 10690517 first10 "K".
- 10690517 first11 "DR".
- 10690517 first12 "D".
- 10690517 first13 "ID".
- 10690517 first14 "LM".
- 10690517 first2 "ML".
- 10690517 first3 "M".
- 10690517 first4 "PL".
- 10690517 first5 "L".
- 10690517 first6 "H".
- 10690517 first7 "GP".
- 10690517 first8 "D".
- 10690517 first9 "S".
- 10690517 isCitedBy 90Y-DOTA-biotin.
- 10690517 issue "2".
- 10690517 journal "Clinical cancer research : an official journal of the American Association for Cancer Research".
- 10690517 last1 "Knox".
- 10690517 last10 "Bryan".
- 10690517 last11 "Fisher".
- 10690517 last12 "Colcher".
- 10690517 last13 "Horak".
- 10690517 last14 "Weiner".
- 10690517 last2 "Goris".
- 10690517 last3 "Tempero".
- 10690517 last4 "Weiden".
- 10690517 last5 "Gentner".
- 10690517 last6 "Breitz".
- 10690517 last7 "Adams".
- 10690517 last8 "Axworthy".
- 10690517 last9 "Gaffigan".
- 10690517 pages "406–14".
- 10690517 pmid "10690517".
- 10690517 title "Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer".
- 10690517 volume "6".
- 10690517 year "2000".